Ontology highlight
ABSTRACT:
SUBMITTER: Oliver SE
PROVIDER: S-EPMC7004397 | biostudies-literature | 2020 Feb
REPOSITORIES: biostudies-literature
Oliver Sara E SE Moore Kelly L KL
MMWR. Morbidity and mortality weekly report 20200207 5
On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningococcal protein conjugate) and hepatitis B (HepB) (recombinant) vaccine, DTaP-IPV-Hib-HepB (Vaxelis; MCM Vaccine Company),* for use as a 3-dose series in infants at ages 2, 4, and 6 months (1). On June 26, 2019, after reviewing data on safety and immunog ...[more]